1.86
price down icon2.62%   -0.05
after-market 시간 외 거래: 1.86
loading
전일 마감가:
$1.91
열려 있는:
$1.9
하루 거래량:
48,973
Relative Volume:
1.00
시가총액:
$183.17M
수익:
$5.15M
순이익/손실:
$-65.35M
주가수익비율:
-0.9347
EPS:
-1.99
순현금흐름:
$-20.85M
1주 성능:
-2.62%
1개월 성능:
+1.36%
6개월 성능:
-36.95%
1년 성능:
-34.51%
1일 변동 폭
Value
$1.8187
$1.90
1주일 범위
Value
$1.77
$1.98
52주 변동 폭
Value
$1.70
$3.7735

Cellectis Adr Stock (CLLS) Company Profile

Name
명칭
Cellectis Adr
Name
전화
-
Name
주소
-
Name
직원
216
Name
트위터
@cellectis
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
CLLS's Discussions on Twitter

CLLS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
CLLS 1.86 183.17M 5.15M -65.35M -20.85M -1.99
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Cellectis Adr Stock (CLLS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-03-17 개시 Bryan Garnier Buy
2022-05-18 업그레이드 Robert W. Baird Neutral → Outperform
2022-01-06 다운그레이드 Wells Fargo Overweight → Equal Weight
2021-11-30 개시 JMP Securities Mkt Outperform
2021-11-08 다운그레이드 William Blair Outperform → Mkt Perform
2021-10-08 다운그레이드 Robert W. Baird Outperform → Neutral
2021-04-28 다운그레이드 Guggenheim Buy → Neutral
2021-03-16 업그레이드 Robert W. Baird Neutral → Outperform
2020-08-19 업그레이드 Citigroup Neutral → Buy
2020-05-12 개시 Robert W. Baird Outperform
2020-03-06 다운그레이드 Goldman Neutral → Sell
2019-10-30 재개 Guggenheim Buy
2019-08-09 개시 BTIG Research Buy
2019-05-24 재개 Citigroup Neutral
2019-03-14 개시 William Blair Outperform
2018-12-19 개시 Goldman Neutral
2018-07-16 개시 Barclays Overweight
2018-03-16 개시 Guggenheim Neutral
2017-09-05 다운그레이드 SunTrust Buy → Hold
2017-09-05 재확인 Wells Fargo Outperform
2017-03-02 개시 Instinet Buy
2017-02-28 개시 Wells Fargo Outperform
2016-04-05 개시 Ladenburg Thalmann Buy
2016-03-02 개시 Sun Trust Rbsn Humphrey Buy
2015-07-20 개시 BofA/Merrill Buy
2015-04-20 개시 Jefferies Buy
2015-04-20 개시 Piper Jaffray Overweight
모두보기

Cellectis Adr 주식(CLLS)의 최신 뉴스

pulisher
Nov 20, 2024

European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN

Nov 20, 2024
pulisher
Nov 12, 2024

Cellectis's SWOT analysis: gene-editing firm's stock faces pivotal year ahead - Investing.com

Nov 12, 2024
pulisher
Nov 06, 2024

Cellectis stock touches 52-week low at $1.75 amid market challenges - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Earnings call: Cellectis reports robust cash reserves, new R&D initiatives - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

Baird maintains $10 target on Cellectis amid strong AZN partnership - Investing.com

Nov 05, 2024
pulisher
Nov 04, 2024

Cellectis earnings missed by $0.03, revenue topped estimates By Investing.com - Investing.com South Africa

Nov 04, 2024
pulisher
Nov 04, 2024

Cellectis earnings missed by $0.03, revenue topped estimates - Investing.com

Nov 04, 2024
pulisher
Oct 30, 2024

Cellectis stock touches 52-week low at $1.77 amid market shifts By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

500: Something went wrong - Investing.com

Oct 30, 2024
pulisher
Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Nudge Lower in Tuesday Trading - MSN

Oct 25, 2024
pulisher
Oct 12, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remains Down for Week - MSN

Oct 12, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Oct 09, 2024
pulisher
Oct 03, 2024

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN

Oct 03, 2024
pulisher
Oct 02, 2024

Monthly information on share capital and company voting rights - GlobeNewswire Inc.

Oct 02, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Cellectis stock rides wave of innovation amid biotech challenges - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Cellectis stock rides wave of innovation amid biotech challenges By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 13, 2024

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN

Sep 13, 2024
pulisher
Sep 06, 2024

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - MSN

Sep 06, 2024
pulisher
Aug 30, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Aug 30, 2024
pulisher
Aug 22, 2024

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN

Aug 22, 2024
pulisher
Aug 21, 2024

European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading - MSN

Aug 21, 2024
pulisher
Jul 26, 2024

A year in review: Cellectis ADR (CLLS)’s performance in the last year - US Post News

Jul 26, 2024
pulisher
Jul 05, 2024

Monthly information on share capital and company voting rights - GlobeNewswire Inc.

Jul 05, 2024
pulisher
Jun 19, 2024

Market Insights: Cellectis ADR (CLLS)'s Notable Drop of -5.84, Closing at 2.02 – DWinneX - The Dwinnex

Jun 19, 2024
pulisher
Jun 18, 2024

Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors - The Globe and Mail

Jun 18, 2024
pulisher
Jun 18, 2024

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results - The Globe and Mail

Jun 18, 2024
pulisher
Jun 14, 2024

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading - MSN

Jun 14, 2024
pulisher
Jun 12, 2024

Cellectis shares target cut by Oppenheimer on revised model post-Q1 results - Investing.com India

Jun 12, 2024
pulisher
Jun 12, 2024

Cellectis shares target cut by Oppenheimer on revised model post-Q1 results By Investing.com - Investing.com UK

Jun 12, 2024
pulisher
May 31, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower - MSN

May 31, 2024
pulisher
May 31, 2024

Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca By Investing.com - Investing.com India

May 31, 2024
pulisher
May 30, 2024

Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca - Investing.com India

May 30, 2024
pulisher
May 18, 2024

European Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday Trading - MSN

May 18, 2024
pulisher
May 17, 2024

European Equities Traded in the US as American Depositary Receipts Fall Again in Tuesday Trading - MSN

May 17, 2024
pulisher
Dec 16, 2023

CellectisADR (CLLS) Price Target Increased by 20.85% to 11.75 - MSN

Dec 16, 2023
pulisher
Nov 01, 2023

AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions - AstraZeneca

Nov 01, 2023
pulisher
Feb 21, 2023

There's a Lot of Upside For Emerging Gene-Editing Companies - The Globe and Mail

Feb 21, 2023
pulisher
Jun 30, 2022

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing - Nature.com

Jun 30, 2022
pulisher
Apr 28, 2022

Cytovia Therapeutics To Go Public Via $600 Million SPAC Merger - Equities News

Apr 28, 2022
pulisher
Apr 09, 2021

Cellectis Completes Sale of $47 million through its ATM program - The Globe and Mail

Apr 09, 2021
pulisher
Mar 29, 2021

Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq - The Globe and Mail

Mar 29, 2021
pulisher
Feb 21, 2021

Current Cathie Wood Portfolio 2021: Ark Invest Holdings - New Trader U

Feb 21, 2021
pulisher
Nov 21, 2019

The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance

Nov 21, 2019
pulisher
Jan 17, 2018

30 Stocks Moving In Wednesday's Pre-Market SessionAdtran Holdings (NASDAQ:ADTN), Adient (NYSE:ADNT) - Benzinga

Jan 17, 2018
pulisher
Oct 18, 2017

7 Gene Editing Companies Investors Should Watch - Nanalyze

Oct 18, 2017
pulisher
Sep 05, 2017

25 Stocks Moving In Tuesday's Pre-Market SessionBioCryst Pharma (NASDAQ:BCRX) - Benzinga

Sep 05, 2017
pulisher
Aug 28, 2017

25 Stocks Moving In Monday's Pre-Market SessionAltisource Portfolio (NASDAQ:ASPS) - Benzinga

Aug 28, 2017
pulisher
Feb 08, 2017

Top 10 Luxury Car Brands In The World - Insider Monkey

Feb 08, 2017
pulisher
Aug 11, 2016

Cellectis (CLLS) Stock Price, News & AnalysisNASDAQ - MarketBeat

Aug 11, 2016
pulisher
Oct 29, 2015

Morning Market GainersCellectis (NASDAQ:CLLS) - Benzinga

Oct 29, 2015

Cellectis Adr (CLLS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):